EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Target DNA-dependent activation mechanism of the prokaryotic immune system SPARTA

Giada Finocchio iD, Balwina Koopal iD, Ana Potocnik iD, Clint Heijstek, Adrie H Westphal, Martin Jinek iD, Daan C Swarts iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkad1248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Giada Finocchio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland. Hauptthemen laut MEDLINE: Prokaryotic Cells, Immunity, Innate. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, Dutch Research Council, COMPASS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In both prokaryotic and eukaryotic innate immune systems, TIR domains function as NADases that degrade the key metabolite NAD+ or generate signaling molecules. Catalytic activation of TIR domains requires oligomerization, but how this is achieved varies in distinct immune systems. In the Short prokaryotic Argonaute (pAgo)/TIR-APAZ (SPARTA) immune system, TIR NADase activity is triggered upon guide RNA-mediated recognition of invading DNA by an unknown mechanism. Here, we describe cryo-EM structures of SPARTA in the inactive monomeric and target DNA-activated tetrameric states. The monomeric SPARTA structure reveals that in the absence of target DNA, a C-terminal tail of TIR-APAZ occupies the nucleic acid binding cleft formed by the pAgo and TIR-APAZ subunits, inhibiting SPARTA activation. In the active tetrameric SPARTA complex, guide RNA-mediated target DNA binding displaces the C-terminal tail and induces conformational changes in pAgo that facilitate SPARTA-SPARTA dimerization. Concurrent release and rotation of one TIR domain allow it to form a composite NADase catalytic site with the other TIR domain within the dimer, and generate a self-complementary interface that mediates cooperative tetramerization. Combined, this study provides critical insights into the structural architecture of SPARTA and the molecular mechanism underlying target DNA-dependent oligomerization and catalytic activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prokaryotic CellsImmunity, InnateImmune SystemNAD+ NucleosidaseRNA, Guide, CRISPR-Cas SystemsSignal TransductionEukaryota

Substanzen

NAD+ NucleosidaseRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.
  • Laboratory of Biochemistry, Wageningen University, 6708 WE Wageningen, the Netherlands.

ORCID-Profile: Giada Finocchio, Balwina Koopal, Ana Potocnik, Martin Jinek, Daan C Swarts

Förderung

  • European Research Council
  • Dutch Research Council
  • COMPASS

Zitieren

APA

Finocchio, G., Koopal, B., Potocnik, A., Heijstek, C., Westphal, A. H., Jinek, M., & Swarts, D. C. (2024). Target DNA-dependent activation mechanism of the prokaryotic immune system SPARTA. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1248

Vancouver

Finocchio G, Koopal B, Potocnik A, Heijstek C, Westphal AH, Jinek M, et al. Target DNA-dependent activation mechanism of the prokaryotic immune system SPARTA. Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1248

BibTeX
@article{Finocchio2024,
  author = {Finocchio, Giada and Koopal, Balwina and Potocnik, Ana and Heijstek, Clint and Westphal, Adrie H and Jinek, Martin and Swarts, Daan C},
  title = {Target DNA-dependent activation mechanism of the prokaryotic immune system SPARTA},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkad1248}
}
Kostenlos starten →